ctrl K

Watchlist Price Alert

Recursion Pharmaceuticals... (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

5.49

0.92 (20.13%)

At close: Jun 06, 2025, 3:59 PM

5.80

5.83%

Pre-market: Jun 09, 2025, 06:33 AM EDT

Recursion Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	58.84M	44.58M	39.68M	10M	3.41M	1.71M
Cost of Revenue	45.24M	42.59M	48.27M	9.1M	63.32M	45.81M
Gross Profit	13.6M	1.99M	-8.59M	896K	-59.91M	-44.1M
Operating Income	-479M	-350.06M	-245.73M	-182.78M	-84.61M	-62.44M
Interest Income	15.76M	19.12M	6.25M	73K	336K	1.74M
Pretax Income	-464.79M	-332.13M	-239.48M	-186.48M	-87.01M	-61.88M
Net Income	-463.66M	-328.07M	-239.42M	-178.07M	-87.88M	-62.52M
Selling & General & Admin	178.18M	110.82M	81.6M	57.68M	25.26M	18.95M
Research & Development	314.42M	241.23M	155.7M	135.27M	63.32M	45.81M
Other Expenses	n/a	-699K	-162K	-178K	-549K	-608K
Operating Expenses	492.61M	351.35M	237.13M	192.78M	88.03M	64.15M
Interest Expense	1.57M	97K	55K	2.95M	1.36M	635K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	537.84M	394.63M	285.41M	192.78M	88.03M	64.15M
Income Tax Expense	-1.13M	-4.06M	-55K	-8.4M	876K	646K
Shares Outstanding (Basic)	274.21M	207.85M	175.54M	170.27M	165.79M	165.79M
Shares Outstanding (Diluted)	274.21M	207.85M	175.54M	170.27M	165.79M	165.79M
EPS (Basic)	-1.69	-1.58	-1.36	-1.05	-0.52	-0.37
EPS (Diluted)	-1.69	-1.58	-1.36	-1.05	-0.52	-0.37
EBITDA	-426.72M	-299.57M	-227.66M	-174.42M	-81.7M	-58.34M
EBIT	-463.22M	-332.03M	-239.42M	-183.53M	-85.65M	-61.88M
Depreciation & Amortization	36.49M	24.4M	19.49M	9.1M	4.44M	3.54M